S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 64,123.99 +0.35%
Next Bullish Trade
Sign in
NDRA

NDRA NDRA

$4.99 -0.28 (-5.31%)
Neutral · -0.28σ
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · NDRA

Momentum reads · latest daily bar
Last
$4.99
-0.28 (-5.31%)
Mkt cap
$6M
Healthcare
RSI(14)
48.1
neutral
Stochastic %K
45.6
neutral
MFI(14)
67.8
neutral
ADX(14)
11.3
weak trend

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 — $-0.0B $-0.0B $-0.0B — —
2025-12-31 — $-0.0B $-0.0B $-0.0B — —
2025-09-30 — $-0.0B $-0.0B $-0.0B — —
2025-06-30 — $-0.0B $-0.0B $-0.0B — —
2025-03-31 — $-0.0B $-0.0B $-0.0B — —
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare NDRA vs peers

Line NDRA up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing NDRA AAPL×
Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE
Popular + MSFT + NVDA + AMZN + GOOG + META + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP
Verdict
Weighted score 0-100 across 2 tickers · best in green
#2
NDRA
score 46.2
4/5 inputs
Ranks second despite zero momentum from 49% off highs, saved only by 100 sentiment showing 401% analyst upside.
value 67quality 20momentum 0sentiment 100
#1
AAPL
score 59.9
5/5 inputs
Dominates with perfect 100 momentum score riding 26.7% 3M gain and 80 quality from 47% gross margins.
value 42growth 50quality 80momentum 100sentiment 33
NDRA
ENDRA Life Sciences Inc.
$4.99
-5.31%
Snapshot
Price 4.99
Day % -5.31
1M % 6.4
3M % -3.48
YTD % 16.32
Market cap 6337684.0
ADV ($) 157544.27277374268
Beta -0.054
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % -3.41
Dist ATR (σ) -0.28
OdysseyHQ grade —
Confluence 1
Valuation
P/E (ttm) —
P/E (fwd) -1.6414473
P/S —
EV/EBITDA -1.002
P/B 3.4652774
FCF yield -0.8557
PEG —
Growth
Revenue yoy —
EPS yoy —
FCF yoy —
Revenue trend 8Q
Quality
Gross margin 0.0
Operating margin 0.0
Net margin 0.0
ROE -4.12598
ROA -1.22329
Debt / Equity 0.26
Interest cov. —
Technicals
RSI(14) 48.1
MACD signal bull
vs 50-DMA -2.24
vs 200-DMA 0.87
vs 52w high -49.34
HV-30 155.1
Sentiment
Analyst rec —
Target upside 401.0
Insider buy-sell 90d —
Risk
Short interest 3.5099998
Days to cover 0.9
Next earnings —
Full NDRA dashboard →
AAPL
Apple Inc.
$333.74
+0.14%
Snapshot
Price 333.74
Day % 0.14
1M % 11.53
3M % 26.7
YTD % 23.15
Market cap 4901757779968.0
ADV ($) 18299230656.54297
Beta 1.097
OdysseyHQ zone
Current zone Blow-off
Dist 21-EMA % 7.28
Dist ATR (σ) 2.78
OdysseyHQ grade —
Confluence 1
Valuation
P/E (ttm) 40.502426
P/E (fwd) 34.625034
P/S 10.858001
EV/EBITDA 30.742
P/B 45.969696
FCF yield 0.0206
PEG 2.69
Growth
Revenue yoy 0.166
EPS yoy 0.218
FCF yoy —
Revenue trend 8Q
Quality
Gross margin 0.47862
Operating margin 0.32275
Net margin 0.27152002
ROE 1.4147099
ROA 0.26229
Debt / Equity 0.8
Interest cov. —
Technicals
RSI(14) 71.6
MACD signal bull
vs 50-DMA 10.27
vs 200-DMA 21.71
vs 52w high -0.37
HV-30 34.2
Sentiment
Analyst rec 2.0
Target upside -4.64
Insider buy-sell 90d -5
Risk
Short interest 0.9599999499999999
Days to cover 2.11
Next earnings 2026-07-30
Full AAPL dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-05-15 -1.09 -1.23 +11.4% +7.1%
2026-03-31 -2.23 -1.23 -81.7% +0.0%
2025-11-14 -2.10 -1.95 -7.7% -7.5%
2025-08-14 -1.71 -2.27 +24.7% +9.5%
2025-05-15 -1.86 -3.91 +52.4% +0.6%
2025-03-31 25.20 -4.10 +714.6% -4.4%
2024-11-15 -9.54 -62.30 +84.7% -8.2%
2024-08-14 -140.00 -122.50 -14.3% -5.5%
2024-05-14 -455.00 -472.50 +3.7% +0.3%
2024-03-28 -297.50 -630.00 +52.8% -30.5%
2023-11-14 -700.00 -752.50 +7.0% +3.2%
2023-08-14 -752.50 -962.50 +21.8% -8.4%
2023-05-15 -1627.50 -1828.75 +11.0% +1.6%
2023-03-14 -1680.00 -1575.00 -6.7% -3.2%
2022-11-14 -1750.00 -1925.00 +9.1% -10.3%
2022-08-15 -2100.00 -1925.00 -9.1% -7.8%
2022-05-12 -2450.00 -2800.00 +12.5% +0.5%
2022-03-30 -2975.00 -2800.00 -6.2% -2.5%
2021-11-15 -2100.00 -2800.00 +25.0% -14.3%
2021-08-12 -2800.00 -2450.00 -14.3% -8.0%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
NDRA ★ $0B — -1.6 — -1.0 3.5 — — — -85.57%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0% —
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% — 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 7.06%

HolderShares% out
Altium Capital Management, LLC 51,900 4.09%
Geode Capital Management, LLC 21,078 1.66%
Vanguard Fiduciary Trust Co 10,121 0.80%
Morgan Stanley 3,546 0.28%
Vanguard Capital Management LLC 2,816 0.22%
UBS Group AG 152 0.01%
Northwestern Mutual Wealth Managemen 19 —
Caitong International Asset Manageme 4 —

Insider activity · 90d

No insider trades for NDRA in last 90d.

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$25.0
Mean
$25.0
High
$25.0
Analysts
1
Recommendation distribution · period 2026-07-01
2
4
1
Revision trend (2026-04-01 → 2026-07-01): net 6 → 6 0 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
8-K 2026-07-09 CURRENT REPORT view ·
8-K 2026-06-26 CURRENT REPORT view ·
8-K 2026-06-25 CURRENT REPORT view ·
8-K 2026-05-28 CURRENT REPORT view ·
10-Q 2026-05-15 QUARTERLY REPORT view ·
8-K 2026-04-21 CURRENT REPORT view ·
10-K 2026-03-31 ANNUAL REPORT view ·
8-K 2026-03-31 CURRENT REPORT view ·
8-K 2026-03-25 CURRENT REPORT view ·
4 2026-03-04 4 view ·
4 2026-03-04 4 view ·
4 2026-01-23 4 view ·
4 2026-01-23 4 view ·
4 2026-01-23 4 view ·
4 2026-01-23 4 view ·
4 2026-01-23 4 view ·
8-K 2025-12-15 CURRENT REPORT view ·
8-K 2025-11-28 CURRENT REPORT view ·
8-K 2025-11-14 CURRENT REPORT view ·
10-Q 2025-11-14 QUARTERLY REPORT view ·
8-K 2025-10-30 CURRENT REPORT view ·
DEF 14A 2025-10-28 DEF 14A view ·
8-K 2025-10-23 FORM 8-K view ·
4 2025-10-15 4 view ·
8-K 2025-10-15 FORM 8-K view ·
10-Q 2025-08-14 FORM 10-Q view ·
8-K 2025-07-23 FORM 8-K view ·
8-K 2025-07-09 FORM 8-K view ·
S-1 2025-07-09 FORM S-1 view ·
4 2025-07-01 4 view ·
4 2025-07-01 4 view ·
4 2025-07-01 4 view ·
8-K 2025-06-11 FORM 8-K view ·
8-K 2025-05-30 FORM 8-K view ·
10-Q 2025-05-15 FORM 10-Q view ·
8-K 2025-05-15 FORM 8-K view ·
10-K 2025-03-31 FORM 10-K view ·
8-K 2025-03-31 FORM 8-K view ·
8-K 2024-11-22 FORM 8-K view ·
10-Q 2024-11-19 FORM 10-Q view ·
8-K 2024-11-15 FORM 8-K view ·
8-K 2024-11-05 FORM 8-K view ·
8-K 2024-10-29 FORM 8-K view ·
DEF 14A 2024-09-16 FORM DEF 14A view ·
4 2024-08-29 PRIMARY DOCUMENT view ·
8-K 2024-08-28 FORM 8-K view ·
8-K 2024-08-23 FORM 8-K view ·
8-K 2024-08-16 FORM 8-K view ·
10-Q 2024-08-14 FORM 10-Q view ·
8-K 2024-08-13 FORM 8-K view ·
8-K 2024-08-09 FORM 8-K view ·
8-K 2024-07-17 FORM 8-K view ·
DEF 14A 2024-06-25 DEF 14A view ·
8-K 2024-06-06 FORM 8-K view ·
8-K 2024-05-20 FORM 8-K view ·
10-Q 2024-05-14 FORM 10-Q view ·
8-K 2024-05-14 FORM 8-K view ·
8-K 2024-05-10 FORM 8-K view ·
8-K 2024-05-03 FORM 8-K view ·
S-1 2024-04-19 FORM S-1 view ·

About NDRA

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Options picks · NDRA

ITM + OTM ideas from the latest scan

Loading…

Congress trades · NDRA

STOCK Act disclosures

Loading…

SEC filings & insiders · NDRA

EDGAR · live

Loading…

Holders · NDRA

Institutions & insider activity

Loading…